| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Gynecology and Obstetrics (J.S., S.I.T., L.F.-S., L.C.G.) and Radiation Oncology (F.K., A.J.G.), Stanford University Medical School, Stanford, California 94305-5317; and Department of Pediatrics (D.R.P.), Baylor College of Medicine, Houston, Texas 77030
Address correspondence and requests for reprints to: Linda C. Giudice, M.D., Ph.D., Department of Gynecology and Obstetrics, Stanford University Medical Center, Room HH-333, Stanford, California 94305-5317. E-mail: giudice{at}stanford.edu
Insulin-like growth factor-binding protein 1 (IGFBP-1) is important in
regulating minute-to-minute IGF bioavailability in the circulation and
is primarily an inhibitor of IGF action systemically and in most
cellular systems. Understanding regulation of IGFBP-1 is, thus,
important in understanding regulation of IGF actions. The IGFBP-1
promoter contains a cAMP response element, and cAMP stimulates IGFBP-1
gene expression at the transcriptional level. Recently, we have found
three consensus sequences for the hypoxia response element in intron 1
of the IGFBP-1 gene. Herein, we have investigated the effects of
hypoxia and a cAMP analog, 8-bromoadenosine-3',5'-cyclic monophosphate
(8-Br-cAMP), on IGFBP-1 expression in HepG2 cells, a model system for
IGFBP-1 gene regulation. HepG2 cells were exposed to normoxia (20%
pO2) or hypoxia (2% pO2) for 24 h in the
absence or presence of 8-Br-cAMP (0.1, 0.5, and 1 mM).
Western ligand blotting revealed IGFBP-1 as the predominant IGFBP
in HepG2-conditioned media, which increased in a dose-dependent
manner after incubation with 8-Br-cAMP in normoxia and hypoxia (3-fold
and 7-fold at 1 mM, respectively). Under hypoxic, compared
with normoxic, conditions, IGFBP-1 protein and messenger RNA (mRNA)
levels increased
10-fold and 20-fold, respectively. In normoxia,
8-Br-cAMP stimulated IGFBP-1 protein and mRNA levels in a
dose-dependent manner (7-fold and 10-fold at 1 mM). Hypoxia
and 8-Br-cAMP showed additive stimulatory effects on IGFBP-1 protein
and mRNA levels (35-fold and 50-fold at 1 mM) that were
time and dose dependent. Primary transcripts of IGFBP-1 mRNA were
increased concordantly with IGFBP-1 mRNA. The half-life of the
IGFBP-1 mRNA was markedly increased (
6-fold) by hypoxia, and cAMP
minimally enhanced this effect. These results demonstrate that hypoxia
and compounds that increase intracellular cAMP additively regulate
IGFBP-1 gene expression by transcriptional and posttranscriptional
mechanisms. Regulation of IGFBP-1 mRNA and protein by cAMP and hypoxia
may be important for understanding the physiologic and pathophysiologic
roles of IGFBP-1.
This article has been cited by other articles:
![]() |
X.-Q. Chen, S.-J. Wang, J.-Z. Du, and X.-C. Chen Diversities in hepatic HIF-1, IGF-I/IGFBP-1, LDH/ICD, and their mRNA expressions induced by CoCl2 in Qinghai-Tibetan plateau mammals and sea level mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R516 - R526. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Stephens, P. McElduff, A. H. Heald, J. P. New, J. Worthington, W. E. Ollier, and J. M. Gibson Polymorphisms in IGF-Binding Protein 1 Are Associated With Impaired Renal Function in Type 2 Diabetes Diabetes, December 1, 2005; 54(12): 3547 - 3553. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Roelfsema, A. J. Gunn, B. H. Breier, J. S. Quaedackers, and L. Bennet The Effect of Mild Hypothermia on Insulin-like Growth Factors After Severe Asphyxia in the Preterm Fetal Sheep Reproductive Sciences, May 1, 2005; 12(4): 232 - 237. [Abstract] [PDF] |
||||
![]() |
D. Mesotten, P. J. D. Delhanty, F. Vanderhoydonc, K. V. Hardman, F. Weekers, R. C. Baxter, and G. van den Berghe Regulation of Insulin-Like Growth Factor Binding Protein-1 during Protracted Critical Illness J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5516 - 5523. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bajoria, S. R. Sooranna, S. Ward, and M. Hancock Placenta as a Link between Amino Acids, Insulin-IGF Axis, and Low Birth Weight: Evidence from Twin Studies J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 308 - 315. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |